goal of new rating boards for innovative therapies is to provide patients throughout Austria with equal access to this area. But the established rules of procedure raise concerns that there will be delays in access to important therapies.
How this can be avoided is the topic of the Rare Diseases Dialogue and the virtual press conference. The following experts are available to media representatives in advance:
- Univ.-Prof. Dr. Michael Freissmuth: Head of the Center for Physiology and Pharmacology, Medical University of Vienna
- Dr. Sylvia Nanz: Medical Director, Pfizer Corporation Austria | Vice Chair, PHARMIG Standing Committee Rare Diseases
- Univ.-Prof. Dr. Barbara Plecko: Head of the Clinical Department of General Pediatrics, Univ. Clinic for Pediatrics and Adolescent Medicine, LKH University Hospital Graz
- Mag. Elisabeth WeigandMBA: Management, Pro Rare Austria
Moderation: Peter RichterPHARMIG
Datum: November 12, 2024, 11:00 a.m., via Microsoft Teams
Please register with Peter Richter at peter.richter@pharmig.at. You will receive the link to the event after registration.
The Rare Diseases Dialog will take place on November 12, 2024 at 4:00 p.m. in the Urania Vienna. Participation is possible both on site and virtually.
About PHARMIG ACADEMY: The PHARMIG ACADEMY is the training and further education institute of PHARMIG, the Austrian pharmaceutical industry association. It offers seminars, courses and training on all healthcare topics. The offer is based on current developments and is aimed at everyone who is interested in or works in the health sector. The format of the RARE DISEASES DIALOG offers all those affected, interested and relevant stakeholders an open discussion platform on current topics in the field of rare diseases.
About PHARMIG: PHARMIG is the voluntary, politically independent interest group of the pharmaceutical industry in Austria. The approximately 120 member companies (as of November 2024) with around 18,000 employees cover a good 95 percent of the domestic pharmaceutical market. PHARMIG and its member companies stand for the best possible security of supply of medicines in the healthcare system and ensure social and medical progress through quality and innovation.
Virtual press conference – PHARMIG ACADEMY Rare Diseases Dialogue
Please register with Peter Richter at peter.richter@pharmig.at.
Datum: November 12, 2024, 11:00 a.m
Art: Press conference
Ort: Microsoft Teams
Austria
OTS ORIGINAL TEXT PRESS RELEASE UNDER THE EXCLUSIVE RESPONSIBILITY OF THE SENDER FOR CONTENT – WWW.OTS.AT | PHA